安定胸痛症候群患者におけるCTストレス心筋灌流、フラクショナルフローリザーブおよび血管造影 (DYNAMITE)
ダイナミック CT ストレス 心筋灌流、CT フラクショナル フロー リザーブ、および冠動脈 CT 血管造影による、安定した胸痛症候群の患者における最適化された治療戦略
The purpose of the DYNAMITE trial (Dynamic CT stress myocardial perfusion, CT fractional flow reserve (FFR-CT) and coronary CT angiography for optimized treatment strategy in patients with chest pain syndromes) is to determine the ability of combined anatomical and functional cardiac CT imaging to improve morbidity and mortality in patients with suspected or known ischemic heart disease.
調査の概要
状態
詳細な説明
Trial design
The DYNAMITE trial is an investigator-initiated, randomised controlled, open-labelled trial conducted in the Capital Region of Copenhagen, Denmark
The following hypothesis will be tested:
- First primary hypothesis: A treatment strategy guided by combined dynamic CT myocardial stress perfusion, FFR-CT and CT coronary angiography improves clinical outcome compared with a conventional management strategy in patients with chronic chest pain syndromes
- Second primary hypothesis: A treatment strategy guided by combined dynamic CT stress myocardial perfusion, FFR-CT and CT coronary angiography results in improved symptom relief compared with a conventional management strategy in patients with chronic chest pain syndromes
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Klaus F Kofoed, MD
- 電話番号:004535458569
- メール:Klaus.kofoed@regionh.dk
研究場所
-
-
-
Copenhagen、デンマーク、2100
- 募集
- Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen
-
コンタクト:
- Klaus F Kofoed, MD, DmSc
- 電話番号:+45 35458569
- メール:Klaus.kofoed@regionh.dk
-
副調査官:
- Jesper J Linde, MD, Ph.D
-
副調査官:
- Lars V Køber, MD,DmSc
-
-
参加基準
適格基準
就学可能な年齢
- 子
- 大人
- 高齢者
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
-
Chest pain in patients with clinically suspected or confirmed ischemic heart disease
-
Clinical indication for non-acute coronary evaluation
-
Status of coronary revascularization
-
With previous coronary revascularization - all patients
-
Without previous coronary revascularization
-
Age≥65 years - all patients with chest pain
-
Age>50 - <65 years - typical angina pectoris and at least one cardiovascular risk factor and/or previous myocardial infarction
- Typical angina requiring all 3 criteria present: a) constrictive discomfort in the front of the chest or in the neck, jaw, shoulder or arm, b) precipitated by physical exertion c) relieved by rest or nitrates within 5 min.
- Cardiovascular risk factors: hypertension, diabetes, hypercholesterolemia, current smoking, family history of ischemic heart disease, previous stroke, peripheral artery disease
-
-
Exclusion Criteria:
- Persistent chest pain and signs of ongoing acute myocardial ischemia requiring acute coronary intervention
- Hospitalization and discharge with the confirmed diagnosis acute coronary syndrome (STEMI or NSTEMI) within the last 6 months
- Severe valvular heart disease as primary diagnosis and/or in potential need of percutaneous or surgical valve treatment
- Known severe heart failure (LVEF less than 35%)
- Language, cultural or mental factors preventing the patient from understanding the informed consent form
- Known atrial fibrillation
- Known renal impairment (estimated Glomerular Filtration Rate below <30 ml/min)
- Known x-ray contrast allergy
- Known intolerance to adenosine infusion
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Intervention group
CT angiography, FFR-CT and dynamic CT stress myocardial perfusion guided treatment strategy |
The study intervention team consists of a specialist in Cardiac CT imaging, an invasive cardiologist, a thoracic surgeon and a cardiology nurse specialist. Treatment strategy defined by the study team based on CT findings involve referral for percutaneous coronary intervention, Coronary Artery Bypass surgery and/or initiation of optimal medical therapy, in addition to potential supplementary diagnostic procedures. |
|
介入なし:Standard care group
Evaluation and treatment strategy according to contemporary clinical practice |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Major Adverse Cardiovascular Events
時間枠:3 years
|
cardiovascular death, acute myocardial infarction, stroke or hospitalization for heart failure |
3 years
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Individual components of the primary endpoint
時間枠:3 years
|
cardiovascular death; acute myocardial infarction; stroke or hospitalization for heart failure |
3 years
|
|
Acute myocardial infarction stratified by subtype
時間枠:12 months
|
Subtypes of acute myocardial infarction according to Fourth Universal Definition 2018 |
12 months
|
|
Hospitalization due to unstable angina pectoris, bleeding, pacemaker and/or implantable/cardioverter defibrillator implantation, surgical or percutaneous heart valve treatment
時間枠:3 years
|
Cardiovascular hospitalizations |
3 years
|
|
All-cause mortality
時間枠:3 years
|
All-cause mortality |
3 years
|
|
All-cause mortality
時間枠:10 years
|
Long-term registry based all-cause mortality at 10 years |
10 years
|
|
Number and type of diagnostic tests performed
時間枠:12 months
|
Cardiac CT, Exercise ECG, perfusion Positron Emission Tomography, perfusion Single-photon emission computed tomography, perfusion magnetic resonance, invasive coronary angiography, invasive fractional flow reserve, intravascular ultrasound, optical coherence tomography |
12 months
|
|
Number of invasive coronary test not leading to coronary revascularization
時間枠:12 months
|
number of invasive procedures |
12 months
|
|
Number of coronary revascularization
時間枠:3 years
|
Coronary bypass surgery and/or percutaneous coronary intervention |
3 years
|
|
Cumulative iodinated contrast volume
時間枠:12 months
|
Cardiac computed tomography, invasive coronary angiography, invasive fractional flow reserve, intravascular ultrasound, invasive optical coherence tomography |
12 months
|
|
Cumulative radiation dose
時間枠:12 months
|
Cardiac CT, perfusion Positron Emission Tomography, perfusion Single-photon emission computed tomography, perfusion magnetic resonance, invasive coronary angiography, invasive fractional flow reserve, intravascular ultrasound, optical coherence tomography |
12 months
|
|
Major procedural complications occuring during procedures (invasive, non-invasive or coronary revascularization)
時間枠:12 months
|
death, cardiac arrest, cardiac arrhytmia, acute myocardial infarction, stroke, bleeding, unplanned revascularization and any complication requiring and/or prolonging hospitalizaation at least 24 hours |
12 months
|
|
Minor procedural complication specific to type of procedure (invasive, non-invasive or during coronary revascularization)
時間枠:12 months
|
Minor procedural complications |
12 months
|
|
Patients diagnosed with non-cardiac disease as likely explanation for symptoms
時間枠:12 months
|
non-cardiac diseases causing chest pain |
12 months
|
|
Seattle Angina Questionaire
時間枠:3 months and 12 months
|
Seattle Angina Questionaire pre-randomization, 3 months and 12 months after randomization |
3 months and 12 months
|
|
Quality of life by EQ-5D-5L instrument
時間枠:3 months and 12 months
|
Quality of life estimated by EQ-5D-5L instrument pre-randomization, 3 months and 12 months after randomization |
3 months and 12 months
|
協力者と研究者
捜査官
- 主任研究者:Klaus F Kofoed, MD、Department of Cardiology, Rigshospitalet, University of Copenhagen, Denmark
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- NNF19OC0057592
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Following publication of the main results of the trial, anonymized data will be made available to other researchers through the Zenodo open data repository.
IPD 共有時間枠
Statistical Analysis Plan and study protocol a time of publication
IPD 共有アクセス基準
Curated by principle investigator according to contemporary law
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。